D. Chassard

发表

Slow release caffeine and prolonged (64‐h) continuous wakefulness: effects on vigilance and cognitive performance

C. Piérard, P. van Beers, M. Beaumont, 2001, Journal of sleep research.

Lack of pharmacokinetic interaction when switching from fluoxetine to milnacipran

D. Chassard, C. Puozzo, P. Hermann, 2006, International clinical psychopharmacology.

Slow-release caffeine: a new response to the effects of a limited sleep deprivation.

D. Batéjat, F. Chauffard, D. Chassard, 2000, Sleep.

Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive

D. Chassard, J. Dingemanse, M. Hoch, 2013, European Journal of Clinical Pharmacology.

Fertility control Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive , nomegestrol acetate and 17 b-estradiol ( NOMAC / E 2 ) : a double-blind , randomized study

S. Christin‐Maitre, N. Chabbert-Buffet, D. Chassard, 2011 .

Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study.

S. Christin‐Maitre, N. Chabbert-Buffet, D. Chassard, 2011, Human reproduction.

A digestive tolerance study of maltitol after occasional and regular consumption in healthy humans

F. Bornet, D. Chassard, Y. Bouhnik, 2003, European Journal of Clinical Nutrition.

[Biological rhythms for anaesthesia and intensive care].

D. Chassard, G. Dispersyn, L. Pain, 2010, Annales francaises d'anesthesie et de reanimation.

Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea

D. Chassard, M. Åkerlund, R. Brouard, 2000, BJOG : an international journal of obstetrics and gynaecology.

Skin Sensitivity to Rocuronium and Vecuronium: A Randomized Controlled Prick-Testing Study in Healthy Volunteers

X. Combes, G. Dhonneur, D. Chassard, 2004, Anesthesia and analgesia.

Pharmacokinetics of Repaglinide in Healthy Caucasian and Japanese Subjects

D. Chassard, M. Thomsen, M. Jørgensen, 2003, Journal of clinical pharmacology.

Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapy

M. Chevallier, J. Lucet, F. Bruneel, 1994, Journal of internal medicine.

Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive

D. Chassard, J. Dingemanse, M. Hoch, 2014, European Journal of Clinical Pharmacology.

A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.

D. Chassard, S. Fitoussi, M. Minutello, 2013, Vaccine.

A randomized prospective trial of the cutaneous and sensory effects of feminine hygiene wet wipes.

D. Chassard, M. Farage, M. Pelisse, 2008, The Journal of reproductive medicine.

checs de la rachianesthsie: problme technique, pharmacologique, anatomique?

D. Chassard, M. Gentili, 2008 .

A single-dose PK study of onapristone including the effect of food on absorption

A. Patat, D. Chassard, A. Bexon, 2015, Cancer Chemotherapy and Pharmacology.

Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects.

A. Patat, D. Chassard, A. Płotka, 2009, British journal of clinical pharmacology.

Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: A double-blind, randomised, dose-finding pilot study

S. Christin‐Maitre, N. Chabbert-Buffet, D. Chassard, 2011, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Fatal haemolytic uraemic syndrome in an AIDS patient.

D. Chassard, L. Cotte, C. Trépo, 1992, European Journal of Medicine.

Pharmacokinetics of pyrimethamine in healthy young volunteers using a new solid phase extraction/HPLC method.

D. Chassard, G. Montay, A. Frydman, 1991, European journal of drug metabolism and pharmacokinetics.

Comparative bioequivalence study of a new levothyroxine solution versus a reference L-thyroxine solution in normal healthy volunteers.

D. Chassard, J. Kerihuel, H. Caplain, 1991, European journal of drug metabolism and pharmacokinetics.

Bioequivalence Study of Two Ibuprofen Formulations Administered Intravenously in Healthy Male Volunteers

D. Chassard, V. Gualano, A. Geneteau, 2004, Clinical drug investigation.

Comparative Bioavailability Study of Cefixime Administered as Tablets or Aqueous Solution

D. Chassard, G. Montay, A. Frydman, 2012, Drugs.

Investigation of the impact of sarizotan on the pharmacokinetics of levodopa

D. Chassard, A. Kovar, S. Krösser, 2007, Biopharmaceutics & drug disposition.

Safety and Pharmacokinetics of P792, a New Blood-Pool Agent: Results of Clinical Testing in Nonpatient Volunteers

D. Chassard, S. Gaillard, B. Bonnemain, 2002, Investigative radiology.

A single centre, open‐label, cross‐over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin®) and topical clindamycin lotion (Dalacin® T) in subjects with mild to moderate acne

D. Chassard, F. Namour, E. Evène, 2006, The Journal of dermatological treatment.

[Failed spinal anaesthesia: technic, pharmacology, anatomy?].

D. Chassard, M. Gentili, 2008, Annales Francaise d'Anesthesie et de Reanimation.

Which bioequivalence study for a racemic drug? Application to milnacipran

D. Chassard, C. Puozzo, D. Deprez, 1998, European Journal of Drug Metabolism and Pharmacokinetics.